StonvexLoading…
StonvexStonvexStonvexCore line items from VEEV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $3.20B | $2.36B | $1.55B | $759.04M |
Operating Income | $916.37M | $670.49M | $429.64M | $233.73M |
Net Income | $908.91M | $664.70M | $428.50M | $228.19M |
EPS (Diluted) | $5.44 | $3.96 | $2.56 | $1.37 |
Total Assets | $8.98B | $8.10B | $8.00B | $7.77B |
Total Liabilities | $1.76B | $1.06B | $1.36B | $1.55B |
Cash & Equivalents | $1.42B | $1.66B | $1.93B | $1.96B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 163.78M | 164.34M | 163.88M | 162.98M |